Terns Pharmaceuticals, Inc.

TERNDelisted May 5, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001831363

SEC filings (opens in a new tab)

Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Terns Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of TERN: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	126	1	156	+31
Shares	65.6M	4.12M	79.5M	+18.0M (+29.4%)
Value	$446.7M	$28.1M	$663.1M	+$244.5M (+58.4%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (54)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to TERN in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	4,698,771	$39.2M	0.00%
Avidity Partners Management LP	2,133,872	$17.8M	0.91%
ExodusPoint Capital Management, LP	1,648,131	$13.7M	0.14%
Bellevue Group AG	1,042,135	$8.69M	0.14%
Boxer Capital, LLC	752,000	$6.27M	0.31%
Affinity Asset Advisors, LLC	600,000	$5.00M	0.78%
Qube Research & Technologies Ltd	456,939	$3.81M	0.01%
StemPoint Capital LP	449,321	$3.75M	1.12%
Altium Capital Management LP	330,000	$2.75M	0.82%
Telemark Asset Management, LLC	300,000	$2.50M	0.25%
Integral Health Asset Management, LLC	300,000	$2.50M	0.29%
J. Goldman & Co LP	203,941	$1.70M	0.07%
Cubist Systematic Strategies, LLC	186,578	$1.56M	0.02%
Walleye Capital LLC	185,795	$1.55M	0.02%
Cinctive Capital Management LP	168,564	$1.41M	0.08%
Voloridge Investment Management, LLC	157,786	$1.32M	0.00%
Alyeska Investment Group, L.P.	150,000	$1.25M	0.01%
Quest Partners LLC	104,535	$871.8K	0.08%
TD Asset Management Inc	99,446	$850.3K	0.00%
Siren, L.L.C.	100,000	$834.0K	0.04%
Martingale Asset Management L P	74,073	$617.8K	0.01%
E. Ohman J:or Asset Management AB	61,775	$515.2K	0.01%
Monashee Investment Management LLC	54,400	$453.7K	0.05%
Squarepoint Ops LLC	53,518	$446.3K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	53,013	$442.1K	0.00%
UBS Oconnor LLC	48,000	$400.3K	0.01%
Scientech Research LLC	45,449	$379.0K	0.08%
Jump Financial, LLC	41,000	$341.9K	0.01%
Dark Forest Capital Management LP	26,269	$219.1K	0.03%
Polymer Capital Management (HK) LTD	24,000	$200.2K	0.05%
SG Americas Securities, LLC	23,810	$199.0K	0.00%
HRT Financial LP	23,637	$197.0K	0.00%
LMR Partners LLP	20,000	$166.8K	0.00%
Acadian Asset Management LLC	19,436	$162.0K	0.00%
Omers Administration Corp	18,300	$152.6K	0.00%
XTX Topco Ltd	17,696	$147.6K	0.01%
Intech Investment Management LLC	17,369	$144.9K	0.00%
Leonteq Securities AG	16,000	$133.4K	0.02%
Brevan Howard Capital Management LP	15,682	$130.8K	0.01%
ProShare Advisors LLC	15,037	$125.4K	0.00%
Baird Financial Group, Inc.	14,209	$118.5K	0.00%
Entropy Technologies, LP	12,700	$105.9K	0.01%
Nebula Research & Development LLC	11,328	$94.5K	0.01%
Axq Capital, LP	11,172	$93.2K	0.03%
Bridgefront Capital, LLC	10,316	$86.0K	0.03%
Sio Capital Management, LLC	10,000	$83.4K	0.04%
Aster Capital Management (DIFC) Ltd	9,316	$77.7K	0.02%
nVerses Capital, LLC	5,700	$47.5K	0.02%
North Star Investment Management Corp.	1,110	$9.26K	0.00%
Penserra Capital Management LLC	868	$7.00K	0.00%
Prestige Wealth Management Group LLC	500	$4.17K	0.00%
Bessemer Group Inc	185	$2.00K	0.00%
Sterling Capital Management LLC	183	$1.53K	0.00%
Capital Performance Advisors LLP	23	$192	0.00%

Sold out (23)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of TERN in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Octagon Capital Advisors LP	1,364,400	$9.29M
Great Point Partners LLC	1,149,406	$7.83M
Franklin Resources Inc	1,122,842	$7.65M
Adage Capital Partners GP, L.L.C.	975,000	$6.64M
Fairmount Funds Management LLC	748,996	$5.10M
Eversept Partners, LP	286,266	$1.95M
DAFNA Capital Management LLC	86,000	$585.7K
Bank of Montreal	40,971	$307.7K
Balyasny Asset Management LLC	19,161	$130.5K
Worth Venture Partners, LLC	17,470	$119.0K
Fox Run Management, L.L.C.	16,503	$112.4K
Alpine Global Management, LLC	16,078	$109.5K
Walleye Trading LLC	15,000	$102.2K
Oxford Asset Management LLP	14,689	$100.0K
Zimmer Partners, LP	14,042	$95.6K
Simplicity Wealth,LLC	10,561	$71.9K
EntryPoint Capital, LLC	9,069	$61.8K
Advisor Group Holdings, Inc.	2,299	$15.7K
Stone House Investment Management, LLC	1,000	$6.81K
Meeder Asset Management Inc	772	$5.26K
US Bancorp	600	$4.09K
Allworth Financial LP	90	$764
National Bank of Canada	100	$679

Not filed for Q3 2024 yet (1)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TERN in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	4,120,508	$28.1M